gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol. 2022;23(5): 615-634. 2. Sadeghi S, Goodarzi A. Various applications of tofacitinib and ruxolitinib (Janus Kinase inhibitors) in dermatology and rheumatology: a review of current evidence and future perspective.